In Malaysia, the group was impacted by the termination and pricing adjustments of certain insurance contracts, which led to a revenue shortfall. The group says they are recalibrating partnership structures to ensure profitability in the Malaysia healthcare market.
Mainboard-listed Thomson Medical Group (SGX:A50
) sinks into the red, reporting a loss for the 1HFY2025 ended Dec 31, 2024 of $12.6 million, as compared to the $4.93 million earnings in 1HFY2024.
This net loss is primarily due to challenges in the Malaysia market, increased interest expenses following the acquisition of Far East Medical Vietnam Limited (FEMVN), and the cessation of non-core transitional care facilities projects in Singapore.
